1. Introduction {#sec0005}
===============

Tumor excision achieving free margins represented the only goal for breast surgeons for many years. Nowadays Breast Conserving Surgery (BCS) represents the gold standard for early stage breast cancer surgical treatment allowing the same long term survival rates as for patients treated with radical mastectomy [@bib0005], [@bib0010].

The modern approach of Oncoplastic Breast Surgery (OPBS) combines the oncological radicality of BCS with the optimal aesthetic result.

The breast reshaping after wide excision is followed by contralateral breast symmetrization in order to reach a pleasant final aesthetic result in a one-stage procedure.

Many oncoplastic approaches have been proposed during the last decades but few cases have been described for multifocal or multicentric cancers [@bib0015], [@bib0020], [@bib0025], [@bib0030], [@bib0035], [@bib0040], [@bib0045].

So called "extreme oncoplastic surgery" is emerging as a new promising concept in breast cancer surgery.

It allows successful breast conservation in selected patients with multicentric tumors.

According to some authors' experience, it could represent a better option than the combination of mastectomy, reconstruction and radiation therapy, from a quality of life point of view [@bib0050].

Moreover we must consider that a good cosmetic result following breast conservation allows the patient to live her life with a normal breast with almost completely preserved sensitivity.

We present an extreme application of oncoplastic breast surgery in a case of multicentric breast cancer, in accordance with the SCARE Statement criteria [@bib0055].

2. Case report {#sec0010}
==============

In January 2015 a 48-year-old woman presented at our observation for breast cancer surgical treatment. She had her breast cancer diagnosis after a screening mammographic examination.

Mammography showed typical features of breast cancer while ultrasonography did not show any typical pattern of neoplasia. Irregular calcifications were detected by mammographic examination in three breast quadrants: infero-central (18 mm), middle-outer (19 mm) and supero-central (8 mm) ([Fig. 1](#fig0005){ref-type="fig"}, [Fig. 2](#fig0010){ref-type="fig"}, [Fig. 3](#fig0015){ref-type="fig"}).

A stereotactic biopsy was performed at the level of the three mammographic suspected areas. Histological findings demonstrated the evidence of malignancy in all the mentioned areas (B5, low grade ductal carcinoma in situ).

Patient's general conditions were good and no systemic pathologies were noted.

Breast volume was considered adequate to perform breast conserving surgery (BCS). Physical examination did not reveal any palpable lesion; axillary lymphadenopathy and skin infiltration were not observed.

In order to perform BCS we localized the three lesions using Tc99-MAA (Technetium 99 m Albumin Aggregated); the sentinel lymph node was localized pre-operatively injecting Tc99m-nanocoll.

We performed three radio-guided cancer resections with wide margins (more than 10 mm). All specimens were sent for radiographic examination showing the radicality of the excision ([Fig. 4](#fig0020){ref-type="fig"}, [Fig. 5](#fig0025){ref-type="fig"}, [Fig. 6](#fig0030){ref-type="fig"}).

A therapeutic inferior pedicle mammaplasty was performed achieving radical resection of the three clusters of microcalcifications.

Then we performed sentinel lymph-node biopsy (SNLB) that was found to be negative for metastasis at intra-operatory frozen section and finally we approached the breast reshaping and the contralateral breast symmetrization with a reduction mastoplasty with a supero-medial pedicle ([Fig. 7](#fig0035){ref-type="fig"}).

The definitive histopathological examination revealed for all the three excised lesions low grade ductal carcinoma in situ (DCIS).

One day after surgery we discharged the patient who showed clinical stability and a pleasant aesthetic result at 1 month ([Fig. 8](#fig0040){ref-type="fig"}).

3. Discussion {#sec0015}
=============

The conserving surgical approach represents over 70% of breast cancer surgical treatment in many European countries; breast surgeons should consider breast conserving surgery as the treatment of choice when technically feasible and oncologically safe [@bib0060], [@bib0065], [@bib0070], [@bib0075].

BCS followed by radiotherapy presents outcomes and overall survival comparable with patients treated with mastectomy [@bib0080], [@bib0085], [@bib0090], [@bib0095], [@bib0100].

In cases requiring large excisions, the oncoplastic techniques represent the only way to avoid major deformities of the breast. Clough et. al developed a suitable oncoplastic atlas offering a quadrant per quadrant solution [@bib0035].

OPBS leads to better cosmetic results if compared with standard conserving approaches and the immediate positive psychological impact on the patient is evident.

Moreover some authors presented better results in terms of quality of life with breast conservation when compared with mastectomy, reconstruction and radiation therapy, because the patients have a better-perceived body image [@bib0105].

Positive margins seem to be less frequent following oncoplastic breast surgery when compared with traditional BCS [@bib0110], [@bib0115], [@bib0120].

However, we do not have long-term data on oncological outcome of so-called "extreme oncoplastic surgery".

Breast conserving therapy bases its rationale on the historical randomized controlled trials of the 1970s [@bib0080], [@bib0085], [@bib0090], [@bib0095], [@bib0100], where the maximum allowed tumor size was 5 cm, so we do not have level I evidences about breast preservation in patients with tumors larger than 5 cm.

Nowadays the use of oncoplastic techniques allows the complete excision of tumors even larger than 5 cm with an accetable aesthetic result. Moreover the standard for adequate surgical margins is nowadays no ink on tumor [@bib0125], so the probability of an oncologically safe procedure increases.

Post-mastectomy radiation therapy (PMRT) could increase the complication rate of implant-based breast reconstruction. Timing of reconstruction in relation of the radiation therapy timing still remains issue of debate [@bib0130].

Autologous flap reconstructions could improve outcomes in radiotreated patients, but not all patients would like to undergo complex and longer interventions with possible significant morbidity and a longer hospital stay.

Furthermore avoiding the use of breast implants allows an inferior number of surgical interventions with obvious economical implications.

Multifocal (MF) and multicentric (MC) breast cancers are known to be more aggressive if compared with unifocal disease. In fact the biological patterns of malignancy (age, grade, HER-2 status, hormone receptor status, lymphovascular invasion) seem to be more aggressive in this group of patients such as the lymph node status [@bib0135], [@bib0140], [@bib0145].

The surgical treatment for MF and MC cancers remains controversial [@bib0150], [@bib0155]. Lynch et al. presented data about MC and MF breast cancers treated by BCS, showing no statistically significant differences in term of local recurrence when compared with patients treated with mastectomy [@bib0160]. Currently the management of this kind of cancers changed considerably: BCS is considered now a worth alternative to mastectomy [@bib0160], [@bib0165], [@bib0170]. A recent paper by Shaikh et al. confirms that MF and MC breast cancers local recurrence rates are not related to the primary surgical approach [@bib0175].

We are sure that MF and MC breast cancer need a multidisciplinary approach, but in our opinion oncoplastic breast conserving surgery could be considered a safe surgical approach for selected patients, even though randomized controlled trials on larger cohorts should be auspicable in order to obtain higher levels of evidence about the use of oncoplastic breast conserving surgery in multicentric breast cancer.
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![Mammography shows the infero-central micro-calcifications.\
(a: cranio-caudal projection, b: medio-lateral projection, c: oblique magnification detail)](gr1){#fig0005}

![Mammography shows the middle-outer micro-calcifications.\
(a: cranio-caudal projection, b: medio-lateral projection, c: cranio-caudal magnification detail)](gr2){#fig0010}

![Mammography shows the supero-central micro-calcifications.\
(a: cranio-caudal projection, b: medio-lateral projection, c: oblique magnification detail)](gr3){#fig0015}

![Radiographic examination showing the radicality of the infero-central lumpectomy.](gr4){#fig0020}

![Radiographic examination showing the radicality of the middle-outer lumpectomy.](gr5){#fig0025}

![Radiographic examination showing the radicality of the supero-central lumpectomy.](gr6){#fig0030}

![The patient was marked for a standard reduction with three lumpectomies and contralateral symmetrization reduction. Pre-operative planning of the inverted-T mastoplasty.](gr7){#fig0035}

![One-month post-operative results.](gr8){#fig0040}
